Related Experiment Video
Updated: Jul 15, 2025
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
LL37-Derived Fragments Improve the Antibacterial Potential of Penicillin G and Ampicillin against
1Department of Chemical Engineering, Worcester Polytechnic Institute, 100 Institute Road, Worcester, MA 01609, USA.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) infections are a severe threat to public health. Antimicrobial peptides (AMPs) are novel and potential antimicrobials with specific antibacterial mechanisms. Our aim was to study the potential of LL37, FK16, and FK13 to enhance the anti-MRSA activity of antibiotics in vitro, particularly penicillin G and ampicillin. Our results showed that FK16 and FK13 have more synergistic inhibitory effects to MRSA strains when combined with penicillin G and ampicillin. In addition, AMPs exhibited strong membrane permeabilizing properties, and membrane permeabilizing effects can provide a possible explanation for the improved antibacterial effects of antibiotics, since permeabilizing AMPs have the potential to increase the access of antibiotics. To further study the electrostatic interactions among cationic AMPs with negatively charged bacteria, we measured the zeta potentials of three MRSA strains and also neutralized three MRSA strains with the addition of cationic AMPs. Further, we demonstrated the connection between membrane permeabilization and zeta potential neutralization. Finally, we treated MRSA strains with AMPs and characterized the MICs of penicillin G and ampicillin. FK16 was the most promising AMP among the three AMPs, since exposure to FK16 decreased the MICs of both penicillin G and ampicillin for all MRSA strains and also demonstrated more synergistic combinations when combined with antibiotics. AMP exposure and subsequent membrane permeabilization provide a possible pathway to re-sensitize drug-resistant bacteria to traditional antibiotics. Re-sensitization may help preserve the effectiveness of traditional antibiotics, thus providing a potential new strategy for fighting MRSA infections.
Insights
Antimicrobial peptides FK16 and FK13 enhance antibiotic effectiveness against Methicillin-resistant Staphylococcus aureus (MRSA). These peptides re-sensitize drug-resistant bacteria by permeabilizing membranes, offering a new strategy to combat MRSA infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
- Antimicrobial peptides (AMPs) offer novel antibacterial mechanisms against resistant pathogens.
- Traditional antibiotics often face resistance challenges, necessitating new therapeutic strategies.
Purpose of the Study:
- To investigate the potential of AMPs (LL37, FK16, FK13) to enhance the efficacy of penicillin G and ampicillin against MRSA in vitro.
- To explore the role of membrane permeabilization and electrostatic interactions in AMP-antibiotic synergy.
- To identify promising AMP candidates for combination therapy against MRSA.
Main Methods:
- In vitro susceptibility testing of MRSA strains with combinations of AMPs and antibiotics.
- Measurement of bacterial zeta potential to assess electrostatic interactions.
- Evaluation of AMP-induced membrane permeabilization.
- Determination of Minimum Inhibitory Concentrations (MICs) for antibiotics in the presence of AMPs.
Main Results:
- FK16 and FK13 demonstrated significant synergistic inhibitory effects when combined with penicillin G and ampicillin against MRSA.
- AMPs exhibited potent membrane permeabilizing properties, correlating with enhanced antibiotic activity.
- FK16 showed the most promising results, decreasing MICs of both antibiotics and exhibiting strong synergistic combinations.
- Zeta potential neutralization was demonstrated and linked to membrane permeabilization.
Conclusions:
- AMP exposure and subsequent membrane permeabilization can re-sensitize drug-resistant bacteria to conventional antibiotics.
- Combination therapy with AMPs like FK16 represents a potential new strategy to overcome MRSA resistance.
- This approach may help preserve the effectiveness of existing antibiotics against challenging infections.
More Related Videos
Related Concept Videos
01:30Development of Antibiotic Resistance
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...
01:23Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
00:57Antibiotic Selection